Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

By T. Ruutu, A. Gratwohl, T. Witte, B. Afanasyev, J. Apperley, A. Bacigalupo, F. Dazzi, P. Dreger, R. Duarte, J. Finke and 15 more. 2014

283 citations recorded by the source corpus.

Subfields: Hematology, Immunology

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Levine
2. Andrew C. Harris
3. E. Holler
4. J. Ferrara
5. R. Young
6. S. Devine
7. C. Chanswangphuwana
8. M. Jagasia

Citations in the corpus

• International, multi-center standardization of acute graft-versus-host disease clinical data collection: a report from the MAGIC consortium (2015, background): “Treatment of GVHD has remain unchanged for over 40 years; no therapies have been identified that improve outcomes when supplementing or replacing systemic corticosteroid treatment, and no treatment has been shown to be reliably effective for steroid-refractory GVHD when tested in phase III clinical ”